Scientists using an experimental treatment have slowed the progression of scrapie, a degenerative central nervous disease caused by prions, in laboratory mice and greatly extended the rodents’ lives,
The risk of developing Alzheimer’s disease increases with age. Susanne Wegmann of the German Center for Neurodegenerative Diseases (DZNE) in Berlin and colleagues have uncovered a possible cause
Fainting is not solely caused by external factors. Your genes also play a part. This has recently been documented by research team from the University of Copenhagen, Statens
A new chemical synthesis strategy to harvest the rich information found in natural products — organic compounds isolated from natural sources — has led to the identification of
Individual differences in cognitive abilities in children and adolescents are partly reflected in variations in their DNA sequence, according to a study published in Molecular Psychiatry. These tiny
The Neurometabolic Diseases research team at IDIBELL and CIBER of Rare Diseases (CIBERER), led by ICREA Professor Aurora Pujol, has uncovered a novel disease of children affecting the
A study from Massachusetts General Hospital (MGH) investigators sheds new light on how the hallmarks of Alzheimer’s disease — amyloid-beta (A-beta) plaques and neurofibrillary tangles containing the protein
Whether it’s the pleasant experience of returning to one’s childhood home over the holidays or the unease of revisiting a site that proved unpleasant, we often find that
An MDC research team reports in the journal Molecular Cell that short protein fibers precede the formation of larger deposits that accumulate in the brains of those affected
Researchers from Case Western Reserve University School of Medicine have found a nanobody that holds promise to advance targeted therapies for a number of neurological diseases and cancer.
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
